Rua Bioscience Limited logo

Rua announces the appointment of new CEO and Chair

Director Appointment8 February 2023RUAHealthcare

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com



FOR PUBLIC RELEASE

NZX Limited

Wellington


Thursday, 9 February 2023



Rua announces the appointment of new CEO and Chair


Rua Bioscience (NZX: RUA) has appointed Paul Naske as Chief Executive Officer. Interim Managing

Director, Anna Stove, will return to Chair the Rua Board as Trevor Burt announces his retirement.


The appointment of CEO is an internal one and is effective 1 March 2023. Paul is a stalwart of the

company, recruited by Rua’s cofounders in 2019. In that time, Paul has substantially progressed

Rua’s global and New Zealand business goals having held roles as Chief Operations Officer and more

recently as Chief Commercial Officer.


Paul oversaw the construction of Rua’s two R&D facilities in Mangaoporo and Gisborne. He

supported the team through the GMP process and was instrumental in navigating the regulatory

environment within which Rua launched its first product for New Zealand patients.


Paul brings a strong background in science and general management, having worked in a diverse

range of industries including roading, construction and agribusiness. Prior to joining Rua, Paul was

the General Manager at Corson Grain, with a focus on increasing the profitability of the Asia-Pacific

business base. Prior to that, he spent 14 years within the Fletcher Challenge group of companies as

General Manager of CSP Pacific (a business unit of Fletcher Building specialising in roading and

construction).


“I’m incredibly proud to take the lead at Rua as we enter an exciting new phase of

commercialisation. It’s an honour to lead a team dedicated to improved patient health and with a

strong commitment to social enterprise,” he says.


Rua Bioscience Chairman, Trevor Burt, is pleased that Rua’s internal succession plan has ensured

Paul’s promotion as the company builds market presence in dynamic domestic and global

environments.


“Paul has proven himself to be an experienced and multi-disciplined executive with intimate

knowledge of our business and the industry. He understands how to maximise global opportunities.

I’ve been particularly impressed by Paul’s ability to provide visible leadership and foster an approach

that is patient-focused and aligned with our values,” he says.


Interim Managing Director, Anna Stove, will return to the Board as Chair. Anna succeeds Trevor Burt,

who was appointed in 2019 and retires due to ill health.


Trevor says “it’s been an honour and a privilege to lead a tenacious Rua team in what has been an

incredibly challenging business environment. I’m sorry to depart, and know I leave the company in

great hands and well-positioned to execute its global strategy.”


ADMINISTRATIVE ANNOUNCEMENT


PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com

In reflecting on Trevor’s contribution over a four-year tenure, Anna says “Trevor has displayed

incredible leadership. His extensive corporate executive and governance experience was invaluable

as we built a diversified and resilient business.


“I look forward to working closely with Paul as we build a focused strategy that ensures sustainable

success. We are now poised for accelerated global growth.”



ENDS


For shareholder enquiries please visit www.ruabio.com, or contact:


Kerry Donovan

Communications and Corporate Affairs Manager

media@ruabio.com

0800 RUABIO

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.